Arie Belldegrun, Director at Cougar Biotechnology, Inc. (CGRB), bought 7,100 shares at $21.10 ($150K) on 2007-05-08, disclosed to the SEC on 2007-05-10.
Open-market purchase of $150k CGRB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ALLO | BUY | 2020-06-04 | $6.9M | — | Filing → |
| ALLO | BUY | 2019-02-13 | $3.5M | — | Filing → |
| KITE | SELL | 2017-09-27 | $9.5M | — | Filing → |